• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.

作者信息

Goncalves-Ramírez Luis R, Gutiérrez Hipólito, Rojas Paol, Cortés Carlos, Serrador Ana, Ramos Benigno, Toro Jairo, Amat-Santos Ignacio J, San Román José A

机构信息

CIBERCV, Hospital Clínico Universitario, Valladolid, Spain.

Institute of Heart Sciences, Hospital Clínico Universitario, Valladolid, Spain.

出版信息

Cardiol J. 2019;26(2):209-211. doi: 10.5603/CJ.2019.0047.

DOI:10.5603/CJ.2019.0047
PMID:31032876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8086657/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbf0/8086657/33c7dbe50071/cardj-26-2-209f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbf0/8086657/33c7dbe50071/cardj-26-2-209f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbf0/8086657/33c7dbe50071/cardj-26-2-209f1.jpg

相似文献

1
Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.支架再狭窄后Absorb生物可吸收血管支架的完全生物吸收
Cardiol J. 2019;26(2):209-211. doi: 10.5603/CJ.2019.0047.
2
First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.首次报道使用药物涂层球囊治疗生物可吸收支架内再狭窄。
Catheter Cardiovasc Interv. 2017 Mar 1;89(4):676-678. doi: 10.1002/ccd.26803. Epub 2016 Sep 21.
3
Restenosis of Coronary Bioresorbable Vascular Scaffolds.冠状动脉生物可吸收血管支架再狭窄
Rev Esp Cardiol (Engl Ed). 2017 Jul;70(7):527-531. doi: 10.1016/j.rec.2017.02.024. Epub 2017 Mar 9.
4
Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response.裸金属支架置入后出现晚期贴壁不良，但生物可吸收支架未出现：关于斑块和器械反应个体内异质性的见解。
J Invasive Cardiol. 2015 Aug;27(8):E171-2.
5
Full scaffold jacket for spontaneous coronary artery dissection of left anterior descending artery with magnesium reabsorbable scaffolds: 1 year follow-up.使用可吸收镁支架治疗左前降支自发性冠状动脉夹层的全支架套：1年随访
Coron Artery Dis. 2020 Aug;31(5):481-484. doi: 10.1097/MCA.0000000000000836.
6
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.第二代可吸收依维莫司洗脱生物可吸收血管支架的 6 个月和 2 年的首次系列评估：多模态影像学研究。
Circ Cardiovasc Interv. 2012 Oct;5(5):620-32. doi: 10.1161/CIRCINTERVENTIONS.112.971549. Epub 2012 Oct 9.
7
Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography.晚期获得性支架贴壁不良和支架不连续可能归因于病理性冠状动脉扩张：光学相干断层扫描的见解
Int J Cardiol. 2015;186:136-8. doi: 10.1016/j.ijcard.2015.03.235. Epub 2015 Mar 18.
8
Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.使用Absorb生物可吸收血管支架进行冠状动脉分叉病变治疗的长期血管内随访
Acta Cardiol. 2018 Aug;73(4):413-414. doi: 10.1080/00015385.2017.1420439. Epub 2017 Dec 25.
9
The Absorb Limits.吸收限度。
J Invasive Cardiol. 2016 Oct;28(10):E122-E123.
10
Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.新生内膜增殖与完全可生物降解血管支架植入术后2年的临床再狭窄相关。
Circ Cardiovasc Imaging. 2014 Jul;7(4):755-7. doi: 10.1161/CIRCIMAGING.114.001727.

引用本文的文献

1
Coronary Vasoreactivity after Complete Bioresorption of Absorb BVS at 5-Year Follow-Up.5年随访时Absorb生物可吸收支架完全生物吸收后的冠状动脉血管反应性
Arq Bras Cardiol. 2021 Feb;116(2 suppl 1):8-11. doi: 10.36660/abc.20190783.

本文引用的文献

1
Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.光学相干断层扫描引导下生物可吸收支架植入：一项系统方案的可行性及初步临床结果
Cardiol J. 2018;25(4):443-458. doi: 10.5603/CJ.a2018.0055. Epub 2018 May 18.
2
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.ESC-EAPCI 工作组关于经皮冠状动脉介入治疗中生物可吸收支架评估和应用的报告：执行摘要。
EuroIntervention. 2018 Jan 20;13(13):1574-1586. doi: 10.4244/EIJ20170912-01.
3
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
生物可吸收支架与金属支架在常规 PCI 中的应用比较。
N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29.
4
Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study.在 ABSORB 队列 B 试验中使用 Absorb 生物可吸收血管支架治疗后管腔偏心度和不对称性的变化：一项为期五年的光学相干断层扫描成像研究。
EuroIntervention. 2017 Apr 7;12(18):e2244-e2252. doi: 10.4244/EIJ-D-16-00740.
5
1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis.冠心病患者应用 Absorb 生物可吸收支架的 1 年结果：一项患者水平的汇总荟萃分析。
Lancet. 2016 Mar 26;387(10025):1277-89. doi: 10.1016/S0140-6736(15)01039-9. Epub 2016 Jan 27.
6
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).生物可吸收血管支架与依维莫司洗脱金属支架治疗 ST 段抬高型心肌梗死：倾向评分匹配比较的 1 年结果：BVS-EXAMINATION 研究（生物可吸收血管支架——依维莫司洗脱冠状动脉支架治疗 ST 段抬高型心肌梗死患者的临床评估）。
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005.
7
OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.经皮冠状动脉介入治疗后 5 年的依维莫司洗脱生物可吸收血管支架的长期血管愈合反应的 OCT 评估。
J Am Coll Cardiol. 2014 Dec 9;64(22):2343-56. doi: 10.1016/j.jacc.2014.09.029. Epub 2014 Dec 1.
8
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较（ABSORB II）：一项随机对照临床试验的临床和操作次要终点 1 年中期分析。
Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.
9
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.经全吸收聚合物雷帕霉素洗脱支架冠状动脉植入治疗初发冠状动脉疾病患者的 5 年临床和功能多层螺旋 CT 血管造影结果：ABSORB 队列 A 试验。
JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017.
10
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.一种生物可吸收依维莫司洗脱冠状动脉支架系统（ABSORB）：2年随访结果及多种成像方法的结果
Lancet. 2009 Mar 14;373(9667):897-910. doi: 10.1016/S0140-6736(09)60325-1.